- Sep. 12, 2024
- Investigator-initiated clinical studies to be launched following confirmation of tumor shrinkage induced by the targeted protein degrader E7820 using J-PDX (Japanese cancer patient-derived tissue transplantation models)
- Jul. 11, 2024
- Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL)
- Jun. 10, 2024
- Dutch-Japanese workshop 'AI for Health' held
- Jun. 10, 2024
- Dr Tatsuhiro Shibata nominated Scientific Council Member of IARC
- May 14, 2024
- World’s Largest Whole Genome Sequencing of Renal Cancer:
mutational signature linked to an unknown exposure discovered in 70% of Japanese samples